Morning Overview on MSN
The FDA cleared Xocova, the first oral antiviral to prevent COVID-19 after exposure, in a five-day pill course shown to cut infections in a phase 3 trial
Households where someone tests positive for COVID-19 now have an oral drug option to protect the people around them. The FDA ...
The approval of a new oral postexposure prophylaxis for COVID-19 marks a significant advancement in the disease's prevention ...
Congressman Rob Bresnahan joined local healthcare leaders at Geisinger Wyoming Valley Medical Center to announce the release ...
Scientists have successfully tested an AI-designed universal coronavirus vaccine in humans for the first time, finding it to ...
The experimental jab is intended to target a wide range of viruses, including those behind deadly outbreaks like Sars, Mers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results